These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29937900)

  • 41. Challenges in delivering antiretroviral treatment in resource poor countries.
    Hosseinipour MC; Kazembe PN; Sanne IM; van der Horst CM
    AIDS; 2002; 16 Suppl 4():S177-87. PubMed ID: 12699015
    [No Abstract]   [Full Text] [Related]  

  • 42. Safety of stavudine in the treatment of HIV infection with a special focus on resource-limited settings.
    Makinson A; Moing VL; Kouanfack C; Laurent C; Delaporte E
    Expert Opin Drug Saf; 2008 May; 7(3):283-93. PubMed ID: 18462186
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Noncommunicable diseases in adolescents with perinatally acquired HIV-1 infection in high-income and low-income settings.
    Innes S; Patel K
    Curr Opin HIV AIDS; 2018 May; 13(3):187-195. PubMed ID: 29432231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Developments in CD4 and viral load monitoring in resource-limited settings.
    Rowley CF
    Clin Infect Dis; 2014 Feb; 58(3):407-12. PubMed ID: 24218101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Report from the Tenth Retrovirus Conference. Clinical trials in resource-poor settings.
    Friedland G
    AIDS Clin Care; 2003 Apr; 15(4):31-2. PubMed ID: 12712944
    [No Abstract]   [Full Text] [Related]  

  • 46. HIV therapy may be given safely in resource-limited settings without routine laboratory monitoring.
    AIDS Patient Care STDS; 2009 Aug; 23(8):680-1. PubMed ID: 19694040
    [No Abstract]   [Full Text] [Related]  

  • 47. HIV drug resistance monitoring in resource constrained countries.
    Jaoko W
    East Afr Med J; 2011 Jan; 88(1):1-3. PubMed ID: 24968595
    [No Abstract]   [Full Text] [Related]  

  • 48. Management of chronic conditions in resource limited settings: multi stakeholders' perception and experiences with receiving and providing integrated HIV, diabetes and hypertension services in Tanzania.
    Shayo EH; Murdoch J; Kiwale Z; Bachmann M; Bakari M; Mbata D; Masauni S; Kivuyo S; Mfinanga S; Jaffar S; Van Hout MC
    BMC Health Serv Res; 2023 Oct; 23(1):1120. PubMed ID: 37858150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention and control of noncommunicable diseases: lessons from the HIV experience.
    Abimbola S; Thomas E; Jan S; McPake B; Wickramasinghe K; Oldenburg B
    Bull World Health Organ; 2019 Mar; 97(3):239-241. PubMed ID: 30992637
    [No Abstract]   [Full Text] [Related]  

  • 50. Priority strategies for sustainable fight against HIV/AIDS in low-income countries.
    Dionisio D; Esperti F; Messeri D; Vivarelli A
    Curr HIV Res; 2004 Oct; 2(4):377-93. PubMed ID: 15544458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Commentary: scaling up HIV treatment in resource-limited countries: the challenge of staff shortages.
    Laurent C
    J Public Health Policy; 2011 May; 32(2):211-8. PubMed ID: 21346787
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Potential use of total lymphocyte count and CD8 T cell immune activation markers in monitoring HIV/AIDS progression and antiretroviral therapy in resource-limited settings].
    Li TS; Xie J
    Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):641-3. PubMed ID: 20979777
    [No Abstract]   [Full Text] [Related]  

  • 53. Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study.
    Scott CA; Iyer HS; McCoy K; Moyo C; Long L; Larson BA; Rosen S
    BMC Public Health; 2014 Mar; 14():296. PubMed ID: 24684772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ethical use of antiretroviral resources for HIV prevention in resource poor settings.
    Rennie S
    Dev World Bioeth; 2013 Aug; 13(2):79-86. PubMed ID: 23724978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Global partnerships to support noncommunicable disease care in low and middle-income countries: lessons from HIV/AIDS.
    Johnson M; Wilkinson J; Gardner A; Kupfer LE; Kimaiyo S; Von Zinkernagel D
    AIDS; 2018 Jul; 32 Suppl 1():S75-S82. PubMed ID: 29952793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leveraging the lessons learned from HIV/AIDS for coordinated chronic care delivery in resource-poor settings.
    Gupta N; Bukhman G
    Healthc (Amst); 2015 Dec; 3(4):215-20. PubMed ID: 26699346
    [No Abstract]   [Full Text] [Related]  

  • 57. Opportunities and options for treatment research in resource-constrained settings.
    Volberding PA
    Clin Infect Dis; 2003 Jul; 37(Suppl 1):S1-3. PubMed ID: 12822126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dried blood spots in HIV monitoring: applications in resource-limited settings.
    Johannessen A
    Bioanalysis; 2010 Nov; 2(11):1893-908. PubMed ID: 21083497
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Training and HIV-treatment scale-up: establishing an implementation research agenda.
    McCarthy EA; O'Brien ME; Rodriguez WR
    PLoS Med; 2006 Jul; 3(7):e304. PubMed ID: 16792434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Global response to HIV: treatment as prevention, or treatment for treatment?
    Sigaloff KC; Lange JM; Montaner J
    Clin Infect Dis; 2014 Jul; 59 Suppl 1(Suppl 1):S7-S11. PubMed ID: 24926037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.